Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HPV Infection clinical trials
7 of 14 indexed HPV Infection trials are currently recruiting.
14 US clinical trials · 7 currently recruiting
HPV Infection is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Frantz Viral Therapeutics, running 3 of these trials.
The research picture
HPV Infection has 14 registered US clinical trials, 7 of them open to new participants right now, about 50% of the total.
- 7
- recruiting participants now
- 50%
- of trials open to enrollment
- 4
- in Phase 3–4 (later-stage)
- 3
- top sponsor: Frantz Viral Therapeutics
Active & Recent Trials
14 total, page 1 of 1
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
NCT05672927
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Qurasense
NCT07281599
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
University of California, San Francisco
NCT07087145
PopSci CHW4CervixHealth
Thomas Jefferson University
NCT07336134
PCOM2 - The Physician Communication Intervention, Version 2.0
University of Colorado, Denver
NCT05336240
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Frantz Viral Therapeutics
NCT04098744
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Frantz Viral Therapeutics
NCT06075264
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
Teal Health
NCT06120205
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
NCT04206813
Game-Based Intervention to Promote HPV Vaccination
Michigan State University
NCT06162676
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
NCT05291871
Intradermal, Fractional Dose of HPV Vaccines:
University of Washington
NCT04235257
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
NCT06959563
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
Frantz Viral Therapeutics
NCT05555862
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the HPV Infection Trial Landscape
14 indexed HPV Infection studies · 7 recruiting (50%).
Phase mix: 4 late (III/IV) vs 4 early (I/II).
Top sponsor: Frantz Viral Therapeutics (3 trials), 9 others listed. 14 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for HPV Infection?
PlainTrial tracks 14 US clinical trials for HPV Infection, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for HPV Infection?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.